Stephen McCraith

1.4k citations

16 papers · 1.1k indexed · h-index 10

Virology top 5%
Molecular Biology top 10%
- RNA and protein synthesis mechanisms 7
- RNA modifications and cancer 6
- RNA Research and Splicing 3
Physiology top 10%
Biochemistry top 10%
Cell Biology
Oncology
- Cancer Immunotherapy and Biomarkers 5
- Colorectal Cancer Treatments and Studies 3
Pulmonary and Respiratory Medicine
- Gastric Cancer Management and Outcomes 4
Surgery
- Esophageal Cancer Research and Treatment 4
Pathology and Forensic Medicine
- Genetic factors in colorectal cancer 3

Co-authors: Eric M. Phizicky Stanley Fields Bernard Moss Elizabeth J. Grayhack Mark R. Martzen Sherry L. Spinelli Gloria M. Culver Heimo Wolinski
Cited by: Virology Molecular Biology Physiology
Journals: Journal of Clinical Oncology (6 papers)Science (2 papers)Journal of Biological Chemistry (2 papers)
Partner nations: United States Belgium Spain

In The Last Decade

Stephen McCraith

16 papers receiving 1.1k citations

Peers

Countries citing papers authored by Stephen McCraith

Since Specialization

Citations

This map shows the geographic impact of Stephen McCraith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen McCraith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen McCraith more than expected).

Fields of papers citing papers by Stephen McCraith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen McCraith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen McCraith. The network helps show where Stephen McCraith may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stephen McCraith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen McCraith Line = papers co-authored together Stephen McCraith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up results from CheckMate 649. Journal of Clinical Oncology ·Yelena Y. Janjigian,Markus Moehler,Jaffer A. Ajani,Uta-Christina Hippler,Marcelo Garrido,Carlos Gallardo,Lucjan Wyrwicz,Kensei Yamaguchi,James M. Cleary,João B. G. Intra,Ricardo Brugés,Michalis V. Karamouzis,Tomasz Skoczylas,Arinilda Campos Bragagnoli,Tianshu Liu,Mustapha Tehfé,Stephen McCraith,Nan Hu,Jennifer Zhang,Kohei Shitara	2025	1
2	First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up of Chinese pts from CheckMate 649. Journal of Clinical Oncology ·Uta-Christina Hippler,Yuxian Bai,Xiaoyan Lin,Burkhard Krueger,Jufeng Wang,Xiaochun Zhang,Hongming Pan,Chunmei Bai,Li Bai,Ying Cheng,Jingdong Zhang,Haijun Zhong,Yi Ba,Wenwei Hu,Rui‐Hua Xu,Weijian Guo,Shukui Qin,Nan Hu,Stephen McCraith,Tianshu Liu	2025	3
3	Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): First results of overall survival (OS) from CheckMate 577. Journal of Clinical Oncology ·Ronan J. Kelly,Jaffer A. Ajani,Jarosław Kużdżał,Thomas Zander,Eric Van Cutsem,Fuad Ardhiansyah,Guillermo Méndez,Josephine Feliciano,Satoru Motoyama,Astrid Lièvre,Hope E. Uronis,Elena Elimova,Cecile Grootscholten,Karen Geboes,Jenny Zhang,Stephen McCraith,H Chrysikopoulos,Ming Lei,James M. Cleary,Markus Moehler	2025	2
4	Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study Journal for ImmunoTherapy of Cancer ·Michael J. Overman,Fabio Gelsomino,Massimo Aglietta,Mark Wong,Mohammad T. Zaafarani Moattar,Gregory Leonard,Pilar García‐Alfonso,Andrew Hill,Antonio Cubillo Gracián,Eric Van Cutsem,Bassel F. El‐Rayes,Stephen McCraith,H Chrysikopoulos,Ming Lei,Sara Lonardi	2024	24
5	First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): 64-month (mo) follow-up from CheckMate 142. Journal of Clinical Oncology ·Heinz‐Josef Lenz,Michael J. Overman,Eric Van Cutsem,María Luisa Limón,Ka Yeung Mark Wong,Alain Hendlisz,Massimo Aglietta,Pilar García‐Alfonso,Bart Neyns,Fabio Gelsomino,Dana B. Cardin,Tomislav Dragovich,Usman Shah,Stephen McCraith,Rui Wang,Ming Lei,Axelle Khouma,Lixian Jin,Sara Lonardi	2024	6
6	First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 Chinese subgroup analysis 4-year (yr) follow-up. Journal of Clinical Oncology ·Lin Shen,Yuxian Bai,Xiaoyan Lin,Wěi Li,Jufeng Wang,Xiaochun Zhang,Hongming Pan,Chunmei Bai,Li Bai,Ying Cheng,Jingdong Zhang,Haijun Zhong,Yi Ba,Wenwei Hu,Rui‐Hua Xu,Weijian Guo,Shukui Qin,Rui Wang,Stephen McCraith,Tianshu Liu	2024	1
7	First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): 64-month (mo) follow-up from CheckMate 142. Journal of Clinical Oncology ·Heinz‐Josef Lenz,Michael J. Overman,Eric Van Cutsem,María Luisa Limón,Mark Wong,Alain Hendlisz,Massimo Aglietta,Pilar García‐Alfonso,Bart Neyns,Fabio Gelsomino,Dana B. Cardin,Tomislav Dragovich,Usman Shah,Stephen McCraith,Ali Hamdi,Ming Lei,Axelle Khouma,Lixian Jin,Sara Lonardi	2023	4
8	The Spatial Organization of Lipid Synthesis in the Yeast Saccharomyces cerevisiae Derived from Large Scale Green Fluorescent Protein Tagging and High Resolution Microscopy Molecular & Cellular Proteomics ·Klaus Natter,Peter Leitner,Moghaddam S.J.,Heimo Wolinski,Stephen McCraith,Stanley Fields,Sepp D. Kohlwein	2005	138
9	Biochemical genomics approach to map activities to genes activities to gene Methods in enzymology on CD-ROM/Methods in enzymology ·O Kuboi,Mark R. Martzen,Stephen McCraith,Sherry L. Spinelli,R. W. Strickland,Cansu Karadere,Ceri E. Van Slyke,Neil M. Barnes,Nora Nwafor,Stanley Fields,Elizabeth J. Grayhack	2002	28
10	Genome-wide analysis of vaccinia virus protein–protein interactions Proceedings of the National Academy of Sciences ·Stephen McCraith,D. Scherber,Bernard Moss,Stanley Fields	2000	228
11	A Biochemical Genomics Approach for Identifying Genes by the Activity of Their Products Science ·Mark R. Martzen,Stephen McCraith,Sherry L. Spinelli,Nora Nwafor,Stanley Fields,Elizabeth J. Grayhack,Eric M. Phizicky	1999	333
12	A 2′-Phosphotransferase Implicated in tRNA Splicing Is Essential in Saccharomyces cerevisiae Journal of Biological Chemistry ·Gloria M. Culver,Stephen McCraith,Sandra A. Consaul,David R. Stanford,Eric M. Phizicky	1997	90
13	An NAD Derivative Produced During Transfer RNA Splicing: ADP-Ribose 1′′-2′′Cyclic Phosphate Science ·Gloria M. Culver,Stephen McCraith,Martin Zillmann,Ryszard Kierzek,Neil R. Michaud,苏海英,Douglas H. Turner,Eric M. Phizicky	1993	89
14	An enzyme from Saccharomyces cerevisiae uses NAD+ to transfer the splice junction 2'-phosphate from ligated tRNA to an acceptor molecule Journal of Biological Chemistry ·Stephen McCraith,Eric M. Phizicky	1991	63
15	A Highly Specific Phosphatase from Saccharomyces cerevisiae Implicated in tRNA Splicing Molecular and Cellular Biology ·Stephen McCraith,Eric M. Phizicky	1990	24
16	A highly specific phosphatase from Saccharomyces cerevisiae implicated in tRNA splicing. Molecular and Cellular Biology ·Stephen McCraith,Eric M. Phizicky	1990	57

About Stephen McCraith

Stephen McCraith is a scholar working on Oncology, Physiology and Virology, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (7 papers), RNA modifications and cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Gastric Cancer Management and Outcomes (4 papers), Esophageal Cancer Research and Treatment (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Genetic factors in colorectal cancer (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Virology (102 citations), Molecular Biology (838 citations) and Physiology (50 citations). Stephen McCraith has collaborated with scholars based in United States, Belgium and Spain. Frequent co-authors include Eric M. Phizicky, Stanley Fields, Bernard Moss, Elizabeth J. Grayhack, Mark R. Martzen, Sherry L. Spinelli, Gloria M. Culver, Heimo Wolinski, Peter Leitner and Sepp D. Kohlwein. Their work appears in journals such as Journal of Clinical Oncology, Science, Journal of Biological Chemistry, Molecular and Cellular Biology and Molecular & Cellular Proteomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact